http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102018133537-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dfca1501abd693c5c11f7371d8759ae
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-72
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-586
filingDate 2018-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7d2460b38d28edae37c27ce2b712aac
publicationDate 2020-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-102018133537-A1
titleOfInvention A medicine used to treat gout and its manufacturing process
abstract The present invention discloses a medicament for treating gout and its manufacturing process. The drug for the treatment of gout includes, by weight, Lotus Plumule 5-15, Spina Date Seed 10-15, Houttuynia cordata 13-20, Angelica sinensis 12-28 and Herba Pyrolae 5-12. The drug for treating gout according to the present invention has other components compared to the drugs of the prior art and can overcome the shortcomings of the drugs in the prior art.
priorityDate 2018-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175

Total number of triples: 35.